Supplemental material
Open access
4,768
Views
47
CrossRef citations to date
0
Altmetric
Research Paper
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
Jie ZhuDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; View further author information
, Hongyu YangDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; View further author information
, Yao ChenSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; View further author information
, Hongzhi LinDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; View further author information
, Qi LiDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; View further author information
, Jun MoDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; View further author information
, Yaoyao BianSchool of Nursing, Nanjing University of Chinese Medicine, Nanjing, ChinaView further author information
, Yuqiong PeiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; View further author information
& Haopeng SunDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China; Correspondence[email protected]
View further author information
show allView further author information
Pages 496-506
|
Received 27 Nov 2017, Accepted 17 Jan 2018, Published online: 06 Feb 2018
Related Research Data
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.
Source:
HAL CCSD
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Source:
Oxford University Press (OUP)
Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Source:
Elsevier BV
Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: Novel sulfamoylcarbamates and sulfamides derived from acetophenones
Source:
Elsevier BV
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.
Source:
Bentham Science Publishers Ltd.
Thioflavine T fluorescence with β/A4 peptides
Source:
Wiley
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.
Source:
Springer Science and Business Media LLC
Cholinesterases: new roles in brain function and in Alzheimer's disease.
Source:
Springer Science and Business Media LLC
The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease
Source:
Wiley
Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease
Source:
Royal Society of Chemistry (RSC)
A review on Alzheimer's disease pathophysiology and its management: an update
Source:
Springer Science and Business Media LLC
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
Source:
Elsevier BV
Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Source:
Elsevier BV
Investigational drugs in Alzheimer's disease: current progress.
Source:
Informa UK Limited
Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer's disease.
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.